Sheng-Bang Yang

466 total citations
16 papers, 348 citations indexed

About

Sheng-Bang Yang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sheng-Bang Yang has authored 16 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Sheng-Bang Yang's work include Prostate Cancer Treatment and Research (4 papers), Cancer, Lipids, and Metabolism (3 papers) and RNA Research and Splicing (3 papers). Sheng-Bang Yang is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Cancer, Lipids, and Metabolism (3 papers) and RNA Research and Splicing (3 papers). Sheng-Bang Yang collaborates with scholars based in China, United States and Macao. Sheng-Bang Yang's co-authors include Weide Zhong, Funeng Jiang, Huichan He, Yongding Wu, Zhaodong Han, Qi-Shan Dai, Yuxiang Liang, Chao Cai, Yanru Zeng and Yanqiong Zhang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Sheng-Bang Yang

16 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sheng-Bang Yang China	10	218	160	88	81	41	16	348
Gaoda Ju China	9	252 1.2×	150 0.9×	118 1.3×	109 1.3×	32 0.8×	20	391
Mohamed Mounir Denmark	5	258 1.2×	141 0.9×	93 1.1×	79 1.0×	49 1.2×	6	365
Subhasree Balakrishnan United States	3	211 1.0×	79 0.5×	76 0.9×	88 1.1×	32 0.8×	3	299
Wolong Zhou China	12	304 1.4×	157 1.0×	79 0.9×	96 1.2×	52 1.3×	21	427
Yaqi Gan China	9	280 1.3×	173 1.1×	80 0.9×	61 0.8×	27 0.7×	10	360
Binbin Cui China	12	197 0.9×	123 0.8×	56 0.6×	87 1.1×	28 0.7×	20	340
Dalong Cao China	8	221 1.0×	148 0.9×	116 1.3×	68 0.8×	46 1.1×	18	361
Ouxuan Liu China	11	151 0.7×	91 0.6×	70 0.8×	66 0.8×	30 0.7×	19	246
Namrata Bhatnagar United States	5	270 1.2×	187 1.2×	53 0.6×	94 1.2×	45 1.1×	6	397

Countries citing papers authored by Sheng-Bang Yang

Since Specialization

Citations

This map shows the geographic impact of Sheng-Bang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng-Bang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng-Bang Yang more than expected).

Fields of papers citing papers by Sheng-Bang Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng-Bang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng-Bang Yang. The network helps show where Sheng-Bang Yang may publish in the future.

Co-authorship network of co-authors of Sheng-Bang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng-Bang Yang. A scholar is included among the top collaborators of Sheng-Bang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng-Bang Yang. Sheng-Bang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Liu, Shaoyou, Jian Chen, Xinyue Mei, et al.. (2025). Depletion of Acetyl‐CoA Carboxylase 1 Facilitates Epithelial‐Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway. MedComm. 6(3). e70126–e70126. 2 indexed citations

Liu, Shaoyou, Yuanfa Feng, Yangjia Zhuo, et al.. (2022). Acetyl-CoA carboxylase 1 depletion suppresses de novo fatty acid synthesis and mitochondrial β-oxidation in castration-resistant prostate cancer cells. Journal of Biological Chemistry. 299(1). 102720–102720. 13 indexed citations

Wang, Yan, Yuxuan Wang, Sheng-Bang Yang, et al.. (2022). EID3 Promotes Cancer Stem Cell‐Like Phenotypes in Osteosarcoma through the Activation of PI3K‐AKT Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2022(1). 5941562–5941562. 5 indexed citations

Hong, Yuan, et al.. (2022). FCGR3A: A new biomarker with potential prognostic value for prostate cancer. Frontiers in Oncology. 12. 1014888–1014888. 3 indexed citations

Dong, Weimin, Sheng-Bang Yang, Zhiming Zhang, et al.. (2022). Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement. Frontiers in Cellular and Infection Microbiology. 12. 1037279–1037279. 13 indexed citations

Liu, Zhangcheng, Chi Chen, Fuxun Yu, et al.. (2021). Association of Total Dietary Intake of Sugars with Prostate‐Specific Antigen (PSA) Concentrations: Evidence from the National Health and Nutrition Examination Survey (NHANES), 2003‐2010. BioMed Research International. 2021(1). 4140767–4140767. 6 indexed citations

Chen, Jiahong, Xiaobo Zhou, Sheng-Bang Yang, et al.. (2020). KIF4A: A potential biomarker for prediction and prognostic of prostate cancer. Clinical and investigative medicine. 43(3). E49–E59. 8 indexed citations

Jiang, Funeng, Lijun Dai, Sheng-Bang Yang, et al.. (2019). Increasing of FKBP9 can predict poor prognosis in patients with prostate cancer. Pathology - Research and Practice. 216(1). 152732–152732. 12 indexed citations

Huang, Yaqiang, Xiaohui Ling, Zhiyun Chen, et al.. (2017). miR-30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein. Molecular Medicine Reports. 16(3). 2431–2438. 20 indexed citations

10.

Cai, Chao, Zhaodong Han, Yanqiong Zhang, et al.. (2015). miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer. Clinical Cancer Research. 21(21). 4922–4934. 103 indexed citations

11.

Cai, Chao, Jinyan Chen, Zhaodong Han, et al.. (2015). Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancer.. PubMed. 8(3). 4186–94. 39 indexed citations

12.

Yang, Sheng-Bang, Yanru Chen, Chao Cai, et al.. (2015). [Association of BCL9 expression with prostate cancer clinicopathological features and survival].. PubMed. 95(32). 2603–6. 2 indexed citations

13.

Zhong, Weide, Huichan He, Zhaodong Han, et al.. (2014). Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence- free survival in patients with prostate cancer. OncoTargets and Therapy. 7. 137–137. 15 indexed citations

14.

Liang, Yuxiang, Jianguo Zhu, Xin Fu, et al.. (2014). CC Chemokine Ligand 18 Correlates with Malignant Progression of Prostate Cancer. BioMed Research International. 2014. 1–10. 41 indexed citations

15.

Jiang, Funeng, Huichan He, Yanqiong Zhang, et al.. (2013). An Integrative Proteomics and Interaction Network-Based Classifier for Prostate Cancer Diagnosis. PLoS ONE. 8(5). e63941–e63941. 25 indexed citations

16.

Zhu, Jianguo, Qi-Shan Dai, Zhaodong Han, et al.. (2013). Expression of SOCSs in human prostate cancer and their association in prognosis. Molecular and Cellular Biochemistry. 381(1-2). 51–59. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact